This company is a global specialty pharmaceutical company inspired to improve the lives of patients whose treatment needs are_not fully addressed by DATE medications. It was_founded in DATE and is based in LOCATION,_France.The company specialises in mergers and acquisitions, proprietary technologies, pharmaceutical formulation, gastrointestinal (GI) and MISC_MISC_MISC (CNS), taste masking and amp ; ODTs, customized drug release, microbiome products.The company 's growth strategy is to_develop and commercialize specialty products by : developing and expanding its robust pipeline ; growing its microbiome franchise ; continuing to_build strong development and commercial partnerships ; and executing strategic and disciplined acquisitions.